-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Downgrades Tenet Healthcare to Neutral, Lowers Price Target to $137

Benzinga·04/15/2025 11:38:02
Listen to the news
Baird analyst Michael Ha downgrades Tenet Healthcare (NYSE:THC) from Outperform to Neutral and lowers the price target from $153 to $137.